| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Oncology Center [S. B. B.] and The Departments of Medicine [A. L. S., S. B. B.] and Pathology [S. R. H.], Johns Hopkins University Medical School, Baltimore, Maryland; NCI-Navy, Medical Oncology Branch [J-G. P., A. F. G.], National Cancer Institute, Bethesda, Maryland; and Department of Medicine [A. L. S., G. D. L.], Wayne State University School of Medicine and Harper Hospital, Detroit, Michigan
Earlier studies of the methylation status of total genomic DNA and of specific genes have demonstrated, predominantly, hypomethylation in human neoplasms. However, we have recently documented the presence of new sites of methylation in the calcitonin gene in human lymphomas (100%), small cell lung carcinomas (92%), and acute myeloid leukemias (95%). We now report that these same novel calcitonin gene methylation sites are also a feature of DNA from human colonic adenomas (13 out of 14 studied), colon carcinomas (4/13), and established colon carcinoma cell lines (18/19), despite the presence of overall genomic DNA hypomethylation in these neoplasms. The data provide further evidence that regional increases in DNA methylation, like gene hypomethylation, occur in benign colonic neoplasms prior to malignant transformation. The fact that abnormalities of calcitonin gene methylation are less frequent in DNA from human colonic carcinomas than from adenomas and colon carcinoma cell culture lines is of special interest. This finding suggests that a more heterogeneous population of cells is present in the carcinomas and that the calcitonin gene hypermethylation may be inherent to cells which are initially selected for growth in culture or are capable of prolonged survival under culture conditions.
1 This study was supported in part by Grants RO1-CA43280 and CA45831 from the National Cancer Institute, by a grant from the Tobacco Research Council, and by the Clayton Research Fund.
2 To whom requests for reprints should be addressed, at Harper HospitalGI, 3990 John R, Detroit, MI 48201.
Received 4/29/88. Revised 9/16/88. Revised 3/ 6/89. Accepted 4/ 5/89.
This article has been cited by other articles:
![]() |
A. Ushmorov, F. Leithauser, O. Sakk, A. Weinhausel, S. W. Popov, P. Moller, and T. Wirth Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma Blood, March 15, 2006; 107(6): 2493 - 2500. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Cottrell, J. Distler, N. S. Goodman, S. H. Mooney, A. Kluth, A. Olek, I. Schwope, R. Tetzner, H. Ziebarth, and K. Berlin A real-time PCR assay for DNA-methylation using methylation-specific blockers Nucleic Acids Res., January 13, 2004; 32(1): e10 - e10. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bariol, C. Suter, K. Cheong, S.-L. Ku, A. Meagher, N. Hawkins, and R. Ward The Relationship between Hypomethylation and CpG Island Methylation in Colorectal Neoplasia Am. J. Pathol., April 1, 2003; 162(4): 1361 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Dong, X. Wang, and B. M. Evers Site-specific DNA methylation contributes to neurotensin/neuromedin N expression in colon cancers Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1139 - G1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kuismanen, M. T. Holmberg, R. Salovaara, P. Schweizer, L. A. Aaltonen, A. de la Chapelle, M. Nystrom-Lahti, and P. Peltomaki Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers PNAS, October 26, 1999; 96(22): 12661 - 12666. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. De Marzo, V. L. Marchi, E. S. Yang, R. Veeraswamy, X. Lin, and W. G. Nelson Abnormal Regulation of DNA Methyltransferase Expression during Colorectal Carcinogenesis Cancer Res., August 1, 1999; 59(16): 3855 - 3860. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Heiskanen, A C Syvanen, H Siitari, S Laine, and A Palotie A novel method to quantitate methylation of specific genomic regions. Genome Res., August 1, 1994; 4(1): 26 - 30. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |